The clinical criteria for offering analysis of BRCA1 and BRCA2 during the study period were designed to roughly lead to a 10% diagnostic yield, and in accordance with that we found that 8.9% of the women had a PV in either of these two genes. This evidence concerns the gene BRCA1 and acquired polycythemia vera.